Nelfinavir-induced urticaria and successful desensitization

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 5, 1998, Pages 875-876

  Demoly, Pascal ^a   Messaad, Djamel ^a   Trylesinski, Aldo ^d   Faucherre, Vincent ^b   Fabre, Jacqueline ^c   Reynes, Jacques ^c   Delmas, Christine ^d   Dohin, Elisabeth ^e   Godard, Philippe ^a   Bousquet, Jean ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b HÔPITAL SAINT ELOI   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

^d Biosphere Medical   (United States)

^e Centre Hospitalier Universitaire ^*

Author keywords

[No Author keywords available]

Indexed keywords

NELFINAVIR; RITONAVIR; SAQUINAVIR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DESENSITIZATION; DIARRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; RASH; URTICARIA;

EID: 0031724409     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70031-4     Document Type: Article

References (5)

1. Carr A, Cooper DA, Penny R. Allergic manifestations of human immunodeficiency virus infection. J Clin Immunol 1991;11:52-64.
2. Deeks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors. A review for clinicians. JAMA 1997;277:145-53.
3. Bonfanti P, Capetti A, Riva P, Testa L, Quirino T. Hypersensitivity reactions during antiretroviral regimens with protease inhibitors. AIDS 1997;11:1301-2.
4. Saag M, Knowles M, Chang Y, Chapman S, Clendeninn NJ. Dual effect of Viracept (nelfinavir mesylate, NFV) in triple combination therapy. In: Program and abstracts of the Interscience Conference of Antimicrobial agents and Chemotherapy. Washington (DC): American Society of Microbiology; 1997 September; Toronto, Canada. Abstract I 101.
5. Webber S, Shetty B, Wu E, Zorbas M. In vitro and in vivo metabolism and cytochrome P450 induction studies with the HIV-1 protease inhibitor, Viracept (AG1343). In: Program and abstracts of the Third Conference on Retroviruses and Opportunistic Infections. Alexandria (VA): Foundation for Retrovirology and Human Health; 1996 Jan 28-Feb 1; Washington, DC. Abstract 144.